LifeStance Health Price to Sales Ratio 2020-2026 | LFST
Historical PS ratio values for LifeStance Health (LFST) over the last 10 years. The current P/S ratio for LifeStance Health as of September 16, 2026 is .
| LifeStance Health P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-09-16 | 12.79 | 3.15 | |
| 2026-06-30 | 10.71 | $4.06 | 2.64 |
| 2026-03-31 | 6.37 | $3.83 | 1.66 |
| 2025-12-31 | 7.04 | $3.66 | 1.92 |
| 2025-09-30 | 5.50 | $3.54 | 1.55 |
| 2025-06-30 | 5.17 | $3.43 | 1.51 |
| 2025-03-31 | 6.66 | $3.36 | 1.98 |
| 2024-12-31 | 7.37 | $3.30 | 2.23 |
| 2024-09-30 | 7.00 | $3.21 | 2.18 |
| 2024-06-30 | 4.91 | $3.09 | 1.59 |
| 2024-03-31 | 6.17 | $2.98 | 2.07 |
| 2023-12-31 | 7.83 | $2.88 | 2.71 |
| 2023-09-30 | 6.87 | $2.77 | 2.48 |
| 2023-06-30 | 9.13 | $2.67 | 3.42 |
| 2023-03-31 | 7.43 | $2.55 | 2.92 |
| 2022-12-31 | 4.94 | $2.43 | 2.04 |
| 2022-09-30 | 6.62 | $2.36 | 2.81 |
| 2022-06-30 | 5.56 | $2.26 | 2.46 |
| 2022-03-31 | 10.11 | $2.18 | 4.64 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $4.991B | $1.424B |
| LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |